Tyler’s Law
Sponsor

Full profile: /officials/L000582
Source: Congress.gov · FEC
Cosponsors (64)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Dan Crenshaw (R-TX-2)Original· 2025-03-10
- David G. Valadao (R-CA-22)Original· 2025-03-10
- Debbie Dingell (D-MI-6)Original· 2025-03-10
- Dina Titus (D-NV-1)Original· 2025-03-10
- Don Bacon (R-NE-2)Original· 2025-03-10
- Eleanor Holmes Norton (D-DC)Original· 2025-03-10
- Juan Ciscomani (R-AZ-6)Original· 2025-03-10
- Marc A. Veasey (D-TX-33)Original· 2025-03-10
- Michael Lawler (R-NY-17)Original· 2025-03-10
- Nanette Diaz Barragán (D-CA-44)Original· 2025-03-10
- Raja Krishnamoorthi (D-IL-8)Original· 2025-03-10
- Robert E. Latta (R-OH-5)Original· 2025-03-10
- Sarah McBride (D-DE)Original· 2025-03-10
- Scott H. Peters (D-CA-50)Original· 2025-03-10
- Sharice Davids (D-KS-3)Original· 2025-03-10
- Sheila Cherfilus-McCormick (D-FL-20)Original· 2025-03-10
- Sydney Kamlager-Dove (D-CA-37)Original· 2025-03-10
- Troy Balderson (R-OH-12)Original· 2025-03-10
- Brian K. Fitzpatrick (R-PA-1)· 2025-03-18
- Rudy Yakym III (R-IN-2)· 2025-03-18
- Greg Landsman (D-OH-1)· 2025-03-24
- Josh Gottheimer (D-NJ-5)· 2025-03-24
- Zachary Nunn (R-IA-3)· 2025-03-24
- Angie Craig (D-MN-2)· 2025-04-01
- Mariannette Miller-Meeks (R-IA-1)· 2025-04-01
- Gus M. Bilirakis (R-FL-12)· 2025-04-07
- Robin L. Kelly (D-IL-2)· 2025-04-08
- Carol D. Miller (R-WV-1)· 2025-04-14
- Young Kim (R-CA-40)· 2025-05-20
- Alexandria Ocasio-Cortez (D-NY-14)· 2025-05-21
- Monica De La Cruz (R-TX-15)· 2025-05-21
- Paul Tonko (D-NY-20)· 2025-06-04
- Gabe Evans (R-CO-8)· 2025-07-16
- Lori Trahan (D-MA-3)· 2025-10-03
- Randy K. Weber, Sr. (R-TX-14)· 2025-10-03
- Jennifer L. McClellan (D-VA-4)· 2025-10-17
- Kim Schrier (D-WA-8)· 2025-10-17
- Janice D. Schakowsky (D-IL-9)· 2025-11-07
- Raul Ruiz (D-CA-25)· 2025-11-12
- Darren Soto (D-FL-9)· 2025-12-12
- Jay Obernolte (R-CA-23)· 2025-12-12
- Nikki Budzinski (D-IL-13)· 2025-12-12
- Robert P. Bresnahan, Jr. (R-PA-8)· 2025-12-18
- Madeleine Dean (D-PA-4)· 2026-01-22
- Chrissy Houlahan (D-PA-6)· 2026-01-30
- Timothy M. Kennedy (D-NY-26)· 2026-01-30
- Ryan Mackenzie (R-PA-7)· 2026-02-20
- Thomas R. Suozzi (D-NY-3)· 2026-02-20
- August Pfluger (R-TX-11)· 2026-03-26
- Chris Pappas (D-NH-1)· 2026-04-09
- Debbie Wasserman Schultz (D-FL-25)· 2026-04-09
- John H. Rutherford (R-FL-5)· 2026-04-15
- Russell Fry (R-SC-7)· 2026-04-15
- Randy Fine (R-FL-6)· 2026-05-19
- Cory Mills (R-FL-7)· 2026-06-02
- Neal P. Dunn (R-FL-2)· 2026-06-10
- Gabe Vasquez (D-NM-2)· 2026-06-24
- Mark Alford (R-MO-4)· 2026-06-24
- Robert Menendez (D-NJ-8)· 2026-06-29
- Joe Neguse (D-CO-2)· 2026-07-13
- Joe Wilson (R-SC-2)· 2026-07-13
- Joyce Beatty (D-OH-3)· 2026-07-14
- Daniel Meuser (R-PA-9)· 2026-07-15
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2025-03-10
Previously
- Energy and Commerce CommitteeReferred To · 2025-03-10
Plain-English Summary
I don't have enough information to write an accurate summary. "Tyler's Law" is a vague title that could refer to several different health-related bills. To provide a meaningful explanation of what this bill would actually do and who it affects, I would need to know the specific policy it addresses—for example, whether it deals with prescription drugs, medical devices, insurance coverage, patient rights, or another health issue. Without access to the bill's text or more detailed subject information, I cannot responsibly summarize its concrete effects.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Full Bill Text
Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 2004 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 2004 To direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES March 10, 2025 Mr. Lieu (for himself, Mr. Latta, Ms. Kamlager-Dove, Mr. Grijalva, Mr. Crenshaw, Mr. Balderson, Mr. Ciscomani, Mr. Valadao, Mr. Lawler, Ms. Davids of Kansas, Ms. Norton, Mr. Krishnamoorthi, Mrs. Cherfilus- McCormick, Ms. Barragan, Mr. Veasey, Ms. Titus, Ms. McBride, Mrs. Dingell, Mr. Bacon, and Mr. Peters) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as ``Tyler's Law''. SEC. 2. TESTING FOR FENTANYL IN HOSPITAL EMERGENCY DEPARTMENTS. (a) Study.--Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall complete a study to determine-- (1) how frequently hospital emergency departments test for fentanyl (in addition to testing for other substances such as amphetamines, phencyclidine, cocaine, opiates, and marijuana) when a patient is experiencing an overdose; (2) the costs associated with such testing for fentanyl; (3) the potential benefits and risks for patients receiving such testing for fentanyl; and (4) how fentanyl testing in hospital emergency departments may impact the experience of the patient, including-- (A) protections for the confidentiality and privacy of the patient's personal health information; and (B) the patient-physician relationship. (b) Guidance.--Not later than 6 months after completion of the study under subsection (a), based on the results of such study, the Secretary of Health and Human Services shall issue guidance on the following: (1) Whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose. (2) How hospitals can ensure that clinicians in their hospital emergency departments are aware of which substances are being tested for in their routinely-administered drug tests, regardless of whether those tests screen for fentanyl. (3) How the administration of fentanyl testing in hospital emergency departments may affect the future risk of overdose and general health outcomes. (c) Definition.--In this section, the term ``hospital emergency department'' means a hospital emergency department as such term is used in section 1867(a) of the Social Security Act (42 U.S.C. 1395dd(a)). <all>
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR955821st Century Federal Writers’ Project ActReferred to Committee · 2026-06-30
- HRES1375Reaffirming the importance of the United States promoting the safety, health, and well-being of refugees and displaced persons in the United States and around the world.Referred to Committee · 2026-06-18
- HR9319Keeping Pets and Families Together ActReferred to Committee · 2026-06-15
- HRES1352Electing Members to certain standing committees of the House of Representatives.Passed House · 2026-06-09